
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
NsGene is committed to developing novel biological products for the treatment of neurological diseases and is focusing on Alzheimers disease, Parkinsons disease and sensorineural hearing loss. NsGene is developing unique treatment options based on the proprietary technology EC Biodelivery(TM), an advanced platform for delivery of therapeutic macromolecules behind the blood-brain-barrier, into the cochlea, or at other sites difficult to reach by conventional drug delivery methods
Developing novel biologics and delivery methods for the treatment of neurological disorders.
Nsgene a/s operates in the Biotechnology research industry.
Nsgene a/s's revenue is 11m - 100m
Nsgene a/s has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.